Azathioprine induced nodular regenerative hyperplasia in IBD patients.

[1]  F. Colina,et al.  Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. , 2008, Liver.

[2]  S. Targan,et al.  6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. , 2003, Gastroenterology.

[3]  J. Belaiche,et al.  Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine , 2003, Alimentary pharmacology & therapeutics.

[4]  S. Targan,et al.  Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine , 2003, American Journal of Gastroenterology.

[5]  M. Anthony,et al.  Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I. , 2002, Journal of women's health & gender-based medicine.

[6]  S. Targan,et al.  6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. , 2002, Gastroenterology.

[7]  B. Vainer,et al.  The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprine , 2001, Alimentary pharmacology & therapeutics.

[8]  S. Krähenbühl,et al.  Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. , 2001, European journal of gastroenterology & hepatology.

[9]  M. Moritz,et al.  Results of Liver Transplantation for Nodular Regenerative Hyperplasia , 2000, The American surgeon.

[10]  I. Arnott,et al.  Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. , 2000, European journal of gastroenterology & hepatology.

[11]  S. Targan,et al.  Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. , 2000, Gastroenterology.

[12]  J. Romagnuolo,et al.  Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. , 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[13]  F. Colina,et al.  Diffuse nodular regenerative hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis. , 1993, The American journal of gastroenterology.

[14]  L. van de Putte,et al.  Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis. , 1990, Annals of the rheumatic diseases.

[15]  H. Whitwell,et al.  Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. , 1988, The American journal of gastroenterology.

[16]  D. Dhumeaux,et al.  [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. , 1991, Gastroenterologie clinique et biologique.

[17]  K. Ishak,et al.  Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. , 1981, Human pathology.